246 related articles for article (PubMed ID: 18164495)
1. A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.
Genest PA; Haimeur A; Légaré D; Sereno D; Roy G; Messier N; Papadopoulou B; Ouellette M
Mol Biochem Parasitol; 2008 Mar; 158(1):95-9. PubMed ID: 18164495
[TBL] [Abstract][Full Text] [Related]
2. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
3. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen.
El Fadili K; Drummelsmith J; Roy G; Jardim A; Ouellette M
Exp Parasitol; 2009 Sep; 123(1):51-7. PubMed ID: 19500579
[TBL] [Abstract][Full Text] [Related]
5. Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.
Holzmuller P; Sereno D; Lemesre JL
Antimicrob Agents Chemother; 2005 Oct; 49(10):4406-9. PubMed ID: 16189135
[TBL] [Abstract][Full Text] [Related]
6. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.
El Fadili K; Messier N; Leprohon P; Roy G; Guimond C; Trudel N; Saravia NG; Papadopoulou B; Légaré D; Ouellette M
Antimicrob Agents Chemother; 2005 May; 49(5):1988-93. PubMed ID: 15855523
[TBL] [Abstract][Full Text] [Related]
7. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
[TBL] [Abstract][Full Text] [Related]
8. Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities.
Holzmuller P; Hide M; Sereno D; Lemesre JL
Infect Genet Evol; 2006 May; 6(3):187-97. PubMed ID: 15905133
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines.
Tessarollo NG; Andrade JM; Moreira DS; Murta SM
Parasitol Int; 2015 Apr; 64(2):125-9. PubMed ID: 25449290
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Sereno D; Holzmuller P; Lemesre JL
Acta Trop; 2000 Jan; 74(1):25-31. PubMed ID: 10643904
[TBL] [Abstract][Full Text] [Related]
11. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
[TBL] [Abstract][Full Text] [Related]
12. High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
Fernandez-Prada C; Sharma M; Plourde M; Bresson E; Roy G; Leprohon P; Ouellette M
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):165-173. PubMed ID: 29602064
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines.
Matrangolo FS; Liarte DB; Andrade LC; de Melo MF; Andrade JM; Ferreira RF; Santiago AS; Pirovani CP; Silva-Pereira RA; Murta SM
Mol Biochem Parasitol; 2013 Aug; 190(2):63-75. PubMed ID: 23831370
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas.
Sereno D; Guilvard E; Maquaire S; Cavaleyra M; Holzmuller P; Ouaissi A; Lemesre JL
Acta Trop; 2001 Dec; 80(3):195-205. PubMed ID: 11700176
[TBL] [Abstract][Full Text] [Related]
15. A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.
Tejera Nevado P; Bifeld E; Höhn K; Clos J
Antimicrob Agents Chemother; 2016 Sep; 60(9):5262-75. PubMed ID: 27324767
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII.
Choudhury K; Zander D; Kube M; Reinhardt R; Clos J
Int J Parasitol; 2008 Oct; 38(12):1411-23. PubMed ID: 18457839
[TBL] [Abstract][Full Text] [Related]
17. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes.
Sereno D; Holzmuller P; Mangot I; Cuny G; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 2001 Jul; 45(7):2064-9. PubMed ID: 11408224
[TBL] [Abstract][Full Text] [Related]
18. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania.
Brochu C; Haimeur A; Ouellette M
Cell Stress Chaperones; 2004; 9(3):294-303. PubMed ID: 15544167
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of nicotinamide/antileishmanial drug combinations.
Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
[TBL] [Abstract][Full Text] [Related]
20. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
